{"title":"Synthesis and antitumor activity of selenocyanate derivatives based on 2-amino-5-(4-chlorophenyl)furan/thiophene scaffolds","authors":"Maixia Liu (Data curation Formal analysis Investigation Methodology) , Lijie Che (Methodology Resources Validation) , Xiyan Tang (Investigation Supervision) , Chunfang Gan (Data curation Software) , Yanmin Huang (Funding acquisition Project administration Writing – review & editing) , Zhiping Liu (Investigation Supervision Writing – original draft Writing – review & editing)","doi":"10.1080/00397911.2025.2545850","DOIUrl":null,"url":null,"abstract":"<div><div>In this study, 2-amino-5-(4-chlorophenyl)furan/thiophene were synthesized <em>via</em> Paal-Knorr and Gewald cyclization strategies. A series of novel furan/thiophene selenocyanate derivatives were constructed by introducing selenocyanate groups with varying chain lengths through amide bonds. All compounds were structurally characterized using NMR and HR-MS analyses. MTT assay for antitumor activity revealed that several compounds exhibited superior efficacy compared to cisplatin. Notably, furan selenocyanate <strong>5c</strong> showed significant inhibitory activity against HepG-2 cells (IC<sub>50</sub> = 8.64 ± 0.94 μM), while thiophene selenocyanate <strong>11d</strong> demonstrated remarkable inhibition against HeLa and MCF-7 cells with IC<sub>50</sub> values of 6.39 and 6.77 μM, respectively. Structure-activity relationship (SAR) analysis indicated that the carbon chain length significantly influenced antitumor activity, with the C<sub>8</sub>-chain thiophene selenocyanate derivative <strong>11d</strong> exhibiting optimal selectivity for HeLa and MCF-7 cells. This study provides important references for development of novel selenium-containing antitumor drugs.</div></div>","PeriodicalId":22119,"journal":{"name":"Synthetic Communications","volume":"55 16","pages":"Pages 1257-1264"},"PeriodicalIF":1.8000,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Synthetic Communications","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/org/science/article/pii/S0039791125000748","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, ORGANIC","Score":null,"Total":0}
引用次数: 0
Abstract
In this study, 2-amino-5-(4-chlorophenyl)furan/thiophene were synthesized via Paal-Knorr and Gewald cyclization strategies. A series of novel furan/thiophene selenocyanate derivatives were constructed by introducing selenocyanate groups with varying chain lengths through amide bonds. All compounds were structurally characterized using NMR and HR-MS analyses. MTT assay for antitumor activity revealed that several compounds exhibited superior efficacy compared to cisplatin. Notably, furan selenocyanate 5c showed significant inhibitory activity against HepG-2 cells (IC50 = 8.64 ± 0.94 μM), while thiophene selenocyanate 11d demonstrated remarkable inhibition against HeLa and MCF-7 cells with IC50 values of 6.39 and 6.77 μM, respectively. Structure-activity relationship (SAR) analysis indicated that the carbon chain length significantly influenced antitumor activity, with the C8-chain thiophene selenocyanate derivative 11d exhibiting optimal selectivity for HeLa and MCF-7 cells. This study provides important references for development of novel selenium-containing antitumor drugs.
期刊介绍:
Synthetic Communications presents communications describing new methods, reagents, and other synthetic work pertaining to organic chemistry with sufficient experimental detail to permit reported reactions to be repeated by a chemist reasonably skilled in the art. In addition, the Journal features short, focused review articles discussing topics within its remit of synthetic organic chemistry.